H20.02
Recurrent acute iridocyclitis
Clinical Classification Guidelines
Medical Intelligence & Overview
Recurrent acute iridocyclitis, classified under ICD-10 code H20.02, is a condition characterized by repeated episodes of inflammation involving the iris and the ciliary body inside the eye. This inflammation can cause discomfort and visual disturbances, and its recurrent nature often requires careful management and monitoring. Though it may affect individuals of all ages, it is particularly significant because of its potential impact on vision if left untreated.
Causes & Symptoms
Clinical Causes: Autoimmune disorders, where the immune system mistakenly attacks eye tissues Infections such as herpes simplex or toxoplasmosis Trauma or injury to the eye Certain systemic diseases like juvenile rheumatoid arthritis Genetic predispositions or familial histories Idiopathic cases where no specific cause is identified
Key Symptoms: Redness in the affected eye Severe eye pain or discomfort Blurred or decreased vision Light sensitivity (photophobia) Presence of floaters or visual disturbances Headache and generalized eye fatigue during episodes Repeated episodes with symptoms that may vary in intensity
Diagnostic & Treatment
Diagnosis Path: Diagnosis of recurrent acute iridocyclitis involves a comprehensive eye examination by an ophthalmologist. The assessment may include visual acuity tests, slit-lamp examination to observe inflammation and cells in the eye, and intraocular pressure measurement. Additional tests such as ocular imaging or blood tests might be performed to identify underlying causes or associated systemic diseases. The recurrent nature of episodes and the characteristic signs help distinguish it from other ocular conditions.
Treatment Protocols: Managing recurrent acute iridocyclitis typically centers on controlling inflammation and preventing recurrences. Treatment strategies may include:
Clinical Advice & FAQs
Billing Guidance
Is H20.02 a billable ICD-10 code?
Yes, H20.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H20.02?
Clinical documentation must specify the nature of Recurrent acute iridocyclitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference